With the risk for tenofovir nephrotoxicity in mind, researchers investigated the impact of treatment with sofosbuvir/ledipasvir with or without tenofovir in patients with HCV/HIV coinfection.
Comorbidities like hepatitis C virus, renal, liver, and chronic pulmonary diseases significantly boosted the risk of hospitalization and costs of patients with HIV, a recent study suggests.
The International Antiviral Society–USA Panel has released a set of updated recommendations for the treatment of patients with HIV, including universal screening for anyone who has been sexually active and...
Data about the prevalence of sleep apnea among individuals with HIV and HF are scarce, although sleep apnea is common among those with HF. A new study investigated.
According to a recent study, nonadherence among Medicaid insured patients with HIV led to an increase in health care resource utilization and overall costs.
Following an analysis of survey data from nearly 12,000 respondents, the Centers for Disease Control and Prevention have released a report on the frequency of HIV testing among various patient populations...
Results from an analysis of more than 2700 HIV-serodiscordant couples suggest that biological changes during and after pregnancy affect the woman’s risk for acquiring HIV infection. For results, read more.
...
A more palatable, yet safe and effective, antiretroviral treatment for HIV-infected children is needed. The PRINCE-2 clinical trial aims to find and test these treatments. In this analysis, the researchers...
